Naveed Sattar Selected Research

Neoplasms (Cancer)

1/2024	Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes.
1/2023	Body composition and lung cancer-associated cachexia in TRACERx.
1/2022	A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk.
12/2021	Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales.
8/2021	Kidney function and cancer risk: An analysis using creatinine and cystatin C in a cohort study.
11/2020	Association of injury related hospital admissions with commuting by bicycle in the UK: prospective population based study.
1/2019	Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies.
1/2018	Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT.
2/2012	Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials.
6/2010	Which circulating antioxidant vitamins are confounded by socioeconomic deprivation? The MIDSPAN family study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naveed Sattar Research Topics

Disease

165	Type 2 Diabetes Mellitus (MODY) 04/2024 - 05/2002
130	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 10/2004
97	Heart Failure 04/2024 - 04/2007
69	Inflammation (Inflammations) 04/2024 - 06/2004
64	Coronary Disease (Coronary Heart Disease) 01/2021 - 07/2002
52	Myocardial Infarction 05/2024 - 07/2006
52	Stroke (Strokes) 01/2024 - 01/2003
52	Insulin Resistance 12/2023 - 11/2002
48	Obesity 04/2024 - 11/2003
33	Weight Loss (Weight Reduction) 04/2024 - 02/2002
29	Hypertension (High Blood Pressure) 03/2024 - 09/2002
29	Vascular Diseases (Vascular Disease) 12/2021 - 05/2004
27	Body Weight (Weight, Body) 01/2024 - 08/2005
27	Rheumatoid Arthritis 01/2023 - 06/2004
21	Diabetes Mellitus 01/2021 - 02/2009
20	COVID-19 10/2023 - 01/2020
17	Atherosclerosis 01/2023 - 11/2003
17	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 04/2007
16	Neoplasms (Cancer) 01/2024 - 01/2002
16	Birth Weight (Birth Weights) 12/2022 - 03/2004
15	Infections 09/2023 - 10/2008
15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 11/2007
14	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 09/2002
12	Chronic Renal Insufficiency 03/2024 - 05/2013
11	Albuminuria 03/2024 - 04/2017
11	ST Elevation Myocardial Infarction 01/2021 - 01/2016
11	Cognitive Dysfunction 01/2020 - 01/2010
10	Non-alcoholic Fatty Liver Disease 01/2022 - 07/2006
10	Pre-Eclampsia (Preeclampsia) 07/2018 - 02/2003
9	Ischemic Stroke 01/2023 - 12/2008
9	Prediabetic State (Prediabetes) 12/2022 - 10/2008
9	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2022 - 05/2011
9	Thrombosis (Thrombus) 01/2021 - 11/2003
8	Atrial Fibrillation 12/2023 - 01/2003
8	Infarction (Infarctions) 01/2019 - 06/2007
8	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2012 - 07/2002
7	Peripheral Arterial Disease 05/2023 - 01/2019
7	Arthritis (Polyarthritis) 01/2022 - 02/2003

Drug/Important Bio-Agent (IBA)

91	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 09/2002
80	LipidsIBA 01/2024 - 01/2003
63	Insulin (Novolin)FDA Link 02/2024 - 07/2002
59	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2008
56	C-Reactive ProteinIBA 04/2024 - 01/2002
44	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 02/2002
40	Triglycerides (Triacylglycerol)IBA 08/2023 - 09/2002
38	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2024 - 04/2007
35	HDL CholesterolIBA 03/2024 - 11/2002
34	pro-brain natriuretic peptide (1-76)IBA 04/2024 - 12/2009
33	CholesterolIBA 03/2024 - 01/2003
30	empagliflozinIBA 05/2024 - 01/2016
30	LeptinIBA 01/2019 - 01/2002
28	AdiponectinIBA 07/2018 - 11/2003
27	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 02/2002
25	LDL CholesterolIBA 11/2023 - 11/2003
24	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2002
23	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2024 - 11/2017
22	Lipoproteins (Lipoprotein)IBA 12/2021 - 01/2003
21	Pravastatin (Pravachol)FDA LinkGeneric 01/2020 - 02/2007
20	omega-Chloroacetophenone (Mace)IBA 01/2024 - 02/2015
19	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2003
19	CreatinineIBA 02/2024 - 08/2013
18	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2024 - 05/2017
16	ApolipoproteinsIBA 10/2020 - 11/2003
15	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2023 - 01/2012
14	Sodium-Glucose Transport ProteinsIBA 04/2024 - 05/2017
13	Glucagon-Like Peptide-1 ReceptorIBA 01/2024 - 10/2019
13	Troponin T (Troponin T1)IBA 12/2023 - 01/2014
13	SodiumIBA 02/2023 - 10/2010
13	AdipokinesIBA 01/2017 - 05/2007
12	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 07/2002
11	Antihypertensive Agents (Antihypertensives)IBA 02/2024 - 09/2002
11	Vitamin D FDA LinkGeneric 12/2023 - 07/2011
10	Hormones (Hormone)IBA 01/2023 - 08/2005
10	oxidized low density lipoproteinIBA 11/2018 - 02/2008
9	tirzepatideIBA 04/2024 - 01/2022
9	CanagliflozinIBA 02/2024 - 11/2020
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 11/2004
9	Fatty Acids (Saturated Fatty Acids)IBA 12/2020 - 05/2004
8	25-hydroxyvitamin DIBA 12/2023 - 05/2011
8	tocilizumab (atlizumab)FDA Link 01/2022 - 03/2012
8	AlbuminsIBA 01/2022 - 01/2004
8	Apolipoproteins E (ApoE)IBA 10/2020 - 02/2008
8	Fibrinogen (Factor I)FDA Link 01/2019 - 07/2002
7	Natriuretic PeptidesIBA 04/2024 - 04/2014
7	AntigensIBA 03/2024 - 07/2002
7	DiureticsIBA 08/2023 - 01/2021
7	InterleukinsIBA 01/2023 - 05/2007
7	HDL LipoproteinsIBA 12/2020 - 09/2002
7	Alanine Transaminase (SGPT)IBA 01/2019 - 11/2004
7	CytokinesIBA 11/2017 - 04/2007
7	von Willebrand FactorIBA 09/2015 - 07/2002
6	Hypoglycemic Agents (Hypoglycemics)IBA 02/2024 - 09/2003
6	Glycoproteins (Glycoprotein)IBA 01/2024 - 01/2018
6	Blood Glucose (Blood Sugar)IBA 01/2024 - 07/2003

Therapy/Procedure

89	Therapeutics 02/2024 - 02/2002
10	Glycemic Control 10/2023 - 02/2014
8	Bariatric Surgery 01/2024 - 06/2010
7	Surgical Amputation (Amputations) 01/2022 - 01/2016
7	Percutaneous Coronary Intervention 01/2020 - 02/2016
6	Precision Medicine 03/2024 - 01/2018